Search Results - "Suchard, Suzanne"
-
1
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
Published in Frontiers in immunology (03-08-2018)“…Agents targeting the PD1-PDL1 axis have transformed cancer therapy. Factors that influence clinical response to PD1-PDL1 inhibitors include tumor mutational…”
Get full text
Journal Article -
2
Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression
Published in PloS one (22-06-2015)“…Programmed T cell differentiation is critically influenced by the complement of costimulatory and coinhibitory signals transmitted during initial antigen…”
Get full text
Journal Article -
3
2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses
Published in The Journal of experimental medicine (10-02-2014)“…Mounting evidence in models of both autoimmunity and chronic viral infection suggests that the outcome of T cell activation is critically impacted by the…”
Get full text
Journal Article -
4
A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety
Published in The Journal of immunology (1950) (01-11-2013)“…Targeting the CD28-CD80/86 pathway with an anti-CD28 antagonist is a promising alternative to current therapies for autoimmunity. However, attempts at…”
Get full text
Journal Article -
5
Assessment of Belatacept-Mediated Costimulation Blockade Through Evaluation of CD80/86-Receptor Saturation
Published in Transplantation (27-03-2009)“…The selective inhibitor of T-cell costimulation, belatacept, blocks CD28-mediated T-cell activation by binding CD80 and CD86 on antigen-presenting cells…”
Get full text
Journal Article -
6
Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope
Published in Journal of molecular biology (17-07-2016)“…Current clinical anti-CD40 biologic agents include both antagonist molecules for the treatment of autoimmune diseases and agonist molecules for…”
Get full text
Journal Article -
7
Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases
Published in The Journal of immunology (1950) (01-05-2014)“…CD40-CD40L interactions play a critical role in regulating immune responses. Blockade of CD40L by Abs, such as the anti-CD40L Ab 5c8, demonstrated positive…”
Get full text
Journal Article -
8
Abatacept binds to the Fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity
Published in Journal of rheumatology (01-11-2007)“…OBJECTIVE: To assess the ability of abatacept to mediate complement-dependent cytotoxicity (CDC) or antibody-dependent cellular cytotoxicity (ADCC) of…”
Get full text
Journal Article -
9
Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699
Published in The Journal of pharmacology and experimental therapeutics (01-12-2015)“…BMS-931699 (lulizumab pegol), a domain antibody (dAb) conjugated with 40-kDa branched polyethylene glycol, is a human anti-CD28 receptor antagonist under…”
Get more information
Journal Article -
10
Potent and Selective Agonists of Sphingosine 1‑Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series
Published in Journal of medicinal chemistry (24-03-2016)“…Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P1–5) and evokes a variety of cellular responses through…”
Get full text
Journal Article -
11
B cells from African American lupus patients exhibit an activated phenotype
Published in JCI insight (16-06-2016)“…Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease driven by both innate and adaptive immune cells. African Americans tend to present…”
Get full text
Journal Article -
12
Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction
Published in Clinical immunology (Orlando, Fla.) (01-01-2008)“…Abstract Abatacept, the first in a new class of agents for RA, modulates CD28-mediated T-cell costimulation. Abatacept was evaluated for its ability to…”
Get full text
Journal Article -
13
An LFA-1 ({alpha}L{beta}2) Small-Molecule Antagonist Reduces Inflammation and Joint Destruction in Murine Models of Arthritis
Published in The Journal of immunology (1950) (01-04-2010)“…LFA-1 appears to play a central role in normal immune responses to foreign Ags. In autoimmune or inflammatory diseases, there is increased expression of LFA-1…”
Get full text
Journal Article -
14
Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1)
Published in Bioorganic & medicinal chemistry letters (15-05-2016)“…[Display omitted] The synthesis and structure–activity relationship (SAR) of a series of pyridyl-isoxazole based agonists of S1P1 are discussed. Compound 5b…”
Get full text
Journal Article -
15
Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)
Published in Journal of medicinal chemistry (13-05-2010)“…Leukocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18 or αLβ2, belongs to the β2 integrin subfamily and is constitutively expressed on all…”
Get full text
Journal Article -
16
Abatacept Does Not Induce Direct Gene Expression Changes in Antigen-Presenting Cells
Published in Journal of clinical immunology (01-07-2009)“…Background It has been proposed that ligation of CD80 and CD86 induces reverse signaling into antigen-presenting cells. In this study, we tested the ability of…”
Get full text
Journal Article -
17
Discovery and Development of 5-[(5S,9R)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1
Published in Journal of medicinal chemistry (30-11-2006)“…LFA-1 (leukocyte function-associated antigen-1), is a member of the β2-integrin family and is expressed on all leukocytes. This letter describes the discovery…”
Get full text
Journal Article -
18
Syk Activation Is Required for Spreading and H2O2 Release in Adherent Human Neutrophils
Published in The Journal of immunology (1950) (15-05-1998)“…Chemoattractant-stimulated polymorphonuclear leukocytes (PMNs) that are adherent to extracellular matrix proteins exhibit a massive, sustained respiratory…”
Get full text
Journal Article -
19
Potent Reversible Inhibitors of the Protein Tyrosine Phosphatase CD45
Published in Journal of medicinal chemistry (24-05-2001)“…The cytosolic portion of CD45, a major transmembrane glycoprotein found on nucleated hematopoietic cells, contains protein tyrosine phosphatase activity and is…”
Get full text
Journal Article -
20
Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold
Published in Bioorganic & medicinal chemistry letters (01-04-2007)“…A new class of lymphocyte function-associated antigen-1 (LFA-1) antagonists is described. Elaboration of the 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold…”
Get full text
Journal Article